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In this paper the main assumption and components of the Disease Management approach and 
programmes are discussed and interpreted on the basis on the classical theory of J.D. Thompson. 
Such interpretation would allow to highlight a counter-intuitive aspect of the approach: in a sector 
usually considered as the prototype of the intensive technology, the DM promises to shift to mediating 
technologies introducing a tighter, standard regulation allowing not only cost-cuttings, but also 
higher quality perceived by patients. These considerations will be instrumental to discuss the 
implication of Disease Management strategies in action in respect with the functional aspects of 
Healthcare Information Systems. Adopting the classification of the core capabilities of an EHR-S 
provided by Tang, the specific features of DM-S, suitable to properly exploit the ICT to support DM 
programs, will be highlighted. Some consideration on the current stage of the IGEA project, i.e. the 
sole nationwide Disease Management program being conducting in Italy, will conclude the paper.  
 





During the last few years the economic sustainability of the health sector have been in danger. The 
need for greater efficiency and an increasing demand for responsiveness to the citizens’ health 
conditions raised, in many countries, the imperative for healthcare systems reforms. The demographic 
aging of population and the consequent growing burden of chronic diseases, the escalating costs of 
care, more demanding citizens as well as evident failures in medicine represent, indeed, a recurring 
scenario in several industrialized countries. Focusing on chronic diseases, such as diabetes, cancer, or 
cardiovascular disease just to name few, the need for strategies aiming to prevent and control them 
becomes, steadily, more compelling. These pathologies represent the most common cause of mortality 
or disability throughout the world (WHO, 2005) and are responsible for almost the 78% of healthcare 
expenditures (Holman, 2004). In a recent report edited by the World Health Organization, 
comprehensive and integrated actions for chronic care management have been defined as “vital 
investments” (WHO 2005).  
An effective management of chronic conditions requires a significant evolution of healthcare systems, 
moving away from traditional models focused on acute disease towards a coordinated and proactive 
organization of care. The main conceptual frameworks promoting this orientation are the Chronic Care 
Model (Bodenheimer et al. 2002) and the Innovative Care for Chronic Conditions (WHO, 2002), an 
adaptation of the former with a more global perspective. These frameworks focus on the continuity of 
care (Haggerty et al., 2003), emphasizing the local dimension of healthcare and promoting the 
integration among some representative basic building blocks of high quality chronic disease care, 
namely healthcare policy, community support, healthcare organization and patients and families. With 
the increase in complexity of patients needs and in specialization of medicine, integrated healthcare 
models are thus getting the scene, and new trends in healthcare service management commonly relies 
on multidisciplinary care-team involved in treatment, as well prevention and monitoring programmes, 
behavioural education and counselling (Wagner, 2002). 
In this context the Disease Management (DM) emerged as a healthcare management strategy for 
chronically ill patients. It promotes the redesign of the healthcare service supply via a multi-
component and Evidence-Based-Medicine-inspired approach. According to it, healthcare systems, 
jointly persecuting the economic efficiency and the quality of the delivered service, proactively acts 
with the aim to prevent, or at least control and delay, the more severe and complex stage of certain 
pathologies. For each of the ill citizens, the DM aims to achieve a continuity of care over time and 
across multiple points of care, in which the multiplicity and variety of players and technical acts are 
harmonized together. 
As follows, in section 2 the main assumption and components of DM approach and programmes are 
discussed. In section 3 a counter-intuitive interpretation of the DM using the lens of the classical 
contribution of J.D. Thompson is discussed. In section 4 an overview of the current state of art of 
Healthcare Information Systems is provided, while some implications of the Disease Management 
strategies enactment in respect of Healthcare Information Systems capabilities are presented in section 
5. Some further considerations conclude the paper in section 6. 
2 THE DISEASE MANAGEMENT APPROACH 
The Disease Management originated in the mid-1990 in USA. Aiming to reduce the total cost of 
healthcare services with no loss on quality, DM fostered the sell and supply of standardized care 
packages, properly tailored for specific disease on the basis on an in-depth knowledge of the pathology 
evolution as well as statistical consideration on possible risks to incur in expensive degenerations or 
comorbidities. Appeared on the scene with a cost-saving inspiration, in some of the following 
conceptualizations, the DM has been considered as a possible response to a set of open issues, like the 
fragmentation of care, the lack of coordination, the bias towards acute treatments and poor emphasis to 
preventive care (Hunter et al., 1997), that, with different extent, have been shared by many healthcare 
systems. 
Due to its twofold orientation to economic efficiency and clinical efficacy, the DM approach has been 
diffused and partly reinterpreted abroad, even in some European Countries. In particular, in some 
nationalized healthcare systems, as in UK and in Italy, the wider conceptualization of DM has been 
strongly influenced by the Clinical Governance movement (Department of Health, 1998). Following 
this perspective, DM have assumed a holistic scope, bringing together managerial, organizational and 
clinical perspectives in order to pursue a timely delivery of appropriate healthcare services on 
accurately defined patients’ categories. More in details, in institutionalized healthcare systems, in 
which the autonomy, the geographical scope, and the publicly providable services of the healthcare 
organizations are ruled, DM has being considered as a viable way to facilitate the integration between 
primary and secondary care (i.e. the IGEA project in Italy). According to this perspective, the 
conceptualization of DM evolves from being a strategy driving the definition of commercial 
healthcare packages to an approach and a process for organizational change. 
Literature lacks of a univocal definition of Disease Management: every statement or components 
description provide only a partial vision of the approach. At first glance, DM is a population based 
management strategy for chronically ill citizens, aiming to combine cost saving and quality 
improvement throughout the redesign of the healthcare delivery system according to an integrated, 
pro-active and multi-factorial approach. 
DM aims to define interventions for the entire spectrum of a disease adding proactive intervention (as 
prevention and screening programmes to reduce the risk of exacerbations and complications) to 
traditional reactive action (as diagnosis, treatment and rehabilitation). An essential DM assumption is 
that proactively provided preventive services and patients monitoring might downsize the clinical 
uncertainly in needs and the complexity of care, thus producing positive effects on care efficacy and 
economic sustainability.  
The promotion of proactive and preventive interventions involves a redefinition of professionals’ and 
patients’ roles. In this sense, DM contributes to the evolution of the traditional relationship between 
caregivers and patients, promoting patient’s awareness, informed and participated decisions related to 
possible clinical strategies and behavioural changes to enable self-managed care. Taking into account 
the importance of educational and couching interventions to contrast improper lifestyles and the need 
to balance together health and social needs, patient empowerment is, therefore, a key component of 
DM.  
DM advocates the standardization of healthcare services via evidence-based integrated care pathways 
(Contenti, Barbini, Albano, 2007). More specifically, according to a population-based approach, 
typical of public health services, healthcare systems hare called to rearrange the delivery of 
appropriate care for well defined categories of high-risk patients, likely candidates to incur in 
expensive complications (Harris, 1996). The orientation to the standardization of care implies that the 
more suitable diseases for DM implementation are those in which variability and uncertainly are 
reduced by the availability of large part of the knowledge on the disease, its evolution and effective 
intervention techniques (Epstein and Sherwood, 1996).  
According to Hunter and Fairfield (1997), DM adopts a patient-centric view of healthcare provision. 
DM effective enactment actually requires to shift from an individual, fragmented and episodic care to 
new paradigms based on integration and coordination of medical resources, along the disease 
continuum and across the entire healthcare delivery system (BCG, 1995). The integration process is 
based on the definition of care pathways (Campbell et al., 1998) shared among players involved in the 
healthcare delivery processes. According to the Evidence Based Health Care conceptualization 
(Rosemberg et al., 1995), that together with the Clinical Governance have strongly influenced the 
evolution of DM, care pathways define optimal sequences of services, and for each intervention the 
minimal professional competences involved as well as the more suitable settings, evaluated on the 
basis of the best clinical evidence and on the local availability of financial, professional and 
infrastructural resources. While clinical practice guidelines (Woolf, 1990) are devoted to supports 
professional decision-making and life-long learning, care pathways are tools for planning, monitoring 
and measuring the healthcare services each player have to deliver. In the case of community care, they 
are jointly developed by different healthcare organizations, who decide to cooperate together in order 
to prevent that part of inefficiencies that may be raised by overlapping of concerns, ambiguities, 
unprotected rights and conflicts.  
Lastly, DM advocates a continuous quality improvement approach in respect to healthcare outcomes, 
resources management and clinical technology.  In this aspect, another relevant component of the DM 
approach cover the definition of measurable outcomes, process and organization parameters 
(Donabedian, 1982), and the enactment of effective procedures to track and assess cost and quality 
performances, by which administrative and clinical audits are performed. In the next section an 
interpretation of the Disease Management approach capturing some organizational aspects is provided. 
3 INTERPRETING THE DISEASE MANAGEMENT APPROACH 
Basing on the classical theory of J.D. Thompson (1967), the DM can be considered as an efficient 
method to reduce the complexity of the medical and healthcare technology. The medical and 
healthcare technology is generally considered as the prototype of intensive technology: a variety of 
techniques is drawn upon in order to achieve a change in some specific objects; the selection, 
combination, and order of application are determined by feedback from the object itself. 
In the healthcare sector, in particular, it is important that the physician would be able to assess the 
health condition, to highlight the most relevant patient’s peculiarities, and to manage all the basic 
techniques of treatment. Then, the physician should be able to define a care strategy, combining the 
basic techniques of treatment, on the basis of the patient’s most urgent needs and preferences. In 
addition, during the treatment, the physician should control the evolution of the health problem and, if 
necessary, modify the care strategy defined for the patient itself. The evolution and the outcomes of 
the care process cannot be foreseen a priori, neither predefined, since it is exposed to a large number 
of contingencies.  
On the other side, even considering the relevant efforts aimed at limiting the discretion of physicians, 
it is not possible to develop a process of care not based on intensive technology. The DM, in its 
general definition, is based on a mediating technology: the process starts with the identification of 
homogeneous groups of subjects (profiling), then, for each category, standardized intervention 
strategies and education activities are outlined. After the standard sequences of intervention are 
designed, the responsibility for each of the acts is attributed to any of the health workers categories 
relevant for the disease in object. Finally, the process of care is applied following the agreed standards. 
The mediating technology, operating in standardized ways, and extensively, allows a more efficient 
planning of the interventions to be carried out, and an improved capability to share resources. As long 
as the mediating technology can be applied on homogeneous cases behaving in foreseeable way, it 
succeeds in achieving higher efficiency than the intensive technology. However, when the mediating 
technology has to deal with heterogeneous and highly variable cases, it easily become strongly 
inefficient. Hence, the efficiency of the application of DM techniques is depending from the capability 
to identify and highlight the non-routine cases, in order to treat them with the traditional (intensive) 
technology. When the single patient shows particular, unintended signs and symptoms, the application 
of the general rules is suspended and he is transferred to more traditional clinical processes (performed 
in conditions of intensive technology). 
From this point of view, then, the DM may be considered as a strategy aiming at introducing a 
“module” operating with a mediating technology within the national healthcare system. Such module 
would be able to treat the patient before the actual insurgence of more dramatic effects of the 
pathology, in order to prevent the surcharge for the global healthcare system and, at the end, to 
improve both the satisfaction of patients and the efficiency of the care system.  
Surprisingly, this shift from intensive to mediating technologies would end not only in cost-cuttings, 
but also in higher quality perceived by patients. In other words, the DM may allow the healthcare 
system to achieve two fundamental but contrasting objectives: the improvement of the value of the 
service supplied to the patient (by means of DM, in fact, the patient can prevent or delay the actual 
appearance of degenerations or comorbidities), and the reduction of the costs related with healthcare 
(the mediating technology is less expensive than the intensive one). In fact, by identifying 
homogeneous classes of chronic patients and by treating them before the onset of worsening, the 
healthcare system is allowed to predefine standard rules of care (also basing on consolidated clinical 
guidelines), to plan in advance the interdependences among the medical actors involved in the care 
process, and to develop closer interactions with the patients (also by training and empowering them). 
In particular, with reference to the coordination choices, the policy-makers decided to privilege the 
adoption of standard rules and routines as primary coordination methods. Such decision is coherent 
with the nature of the DM services, designed to efficiently treat pathologic, homogeneous cases.  
The decision to adopt a basic coordination strategy is also motivated by the fact that the physicians 
working in the DM process are requested to behave in orderly and integrated way, but they don’t need 
to interact and to communicate with each other for the care of the patient: they are in conditions of 
pooled interdependence (Thompson, 1967). Finally, such decisions are coherent with the DM’s focus 
on economic efficiency and viability, in fact standardization requires less interactions and direct 
communications among the team members than other coordination strategies. 
4 HEALTHCARE INFORMATION SYSTEMS 
Disease management has a great potential to improve the care of people with chronic illnesses, and 
Information and Communication Technology (ICT) is an effective tool in fostering the adoption of this 
approach to care. Indeed, computerized information processing facilities related to statistical analysis 
on the distribution of resources consumed in healthcare, is one of the historical precursor to the raise 
of the DM approach (Coughlin et al., 2006).  
Even if with some delay in respect with other information-intensive sectors (e.g. finance), the role of 
ICT for the innovation and the sustainability of the healthcare industry, as a whole, is increasingly 
being promoted and recommended worldwide (IOM, 2001, CEC 2004). Over time many terms have 
been adopted to refer to technical standards, software infrastructures and applications adopted in this 
specific domain; the branch of “Medical Informatics” and “Telemedicine” are now part of the more 
general domain of eHealth.  
In the academic community several efforts to define e-Health and its scope have been provided 
(Eysenbach, 2001; Oh et al., 2005; Pagliari et al., 2005; Jones et al., 2005). However a general and 
comprehensive definition that may be adopted here is the one provided by the Europe’s Information 
Society ICT for Health Unit, according to which e-Health “describes the application of information 
and communications technologies across the whole range of functions that affect the health sector, 
from the doctor to the hospital manager, via nurses, data processing specialists, social security 
administrators and - of course - the patients”. Consistently with this definition, e-Health applications 
and systems are becoming pervasive, being designed, implemented and adopted to support, from time 
to time, an interdependent set of clinical, administrative, managerial, epidemiological and relational 
needs and processes. In details, in (Pagliari et al., 2005) e-Health domain is structured in four areas: (i) 
Professional Clinical Informatics related to functionalities and technologies for healthcare 
professionals; (ii) Consumer Health Informatics devoted to patients’ information, education and 
empowerment aspects; (iii) Healthcare Business Management dealing with billing, tracking and 
assessing issues; and (iv) Electronic Health Records (EHR). While the former three directly refer to 
well identified categories of users, the last represents, in a patient-centric view of healthcare service 
delivery, the core element for Healthcare Information System.  
More precisely, since 1998, Iakovidis (1998) put in evidence the distinction between EHR, assumed as 
electronic containers of medical documentations, and EHR Systems (EHR-S) operating on them. 
Whereas dealing with tightly connected issues, the former is related with medical terms coding and 
classification, patients’ information representation and data structures; the latter with software systems 
capabilities, i.e. functional and non functional aspects of EHR-S. In networked community care 
environments, EHR-S can be seen as multifaceted “infostructures” in which geographically distributed 
and heterogeneous sources of information and data are dynamically integrated, filtered, and composed 
to assist particular needs of specific players. Actually, according to the analysis on primary and 
secondary use of EHR-S discussed in (Tang, 2003), they must support the delivery of personal health 
care services, including care delivery (e.g., care processes), care management, care support processes, 
administrative processes as well as education, regulation (e.g., credentialing), clinical and health 
services research, public health, and policy making.  
Neglecting here non-functional requirements, related to dependable aspects of software platforms 
(Laprie, 1992), the core capabilities of an EHR-S may be described by the eight categories depicted in 
the following table (Tang, 2003).  
 
Health information and data 
Capabilities of processing a wide variety of structured or unstructured, 
textual or multimedia datasets and documents (e.g. demographics, 
medication list, allergies, laboratory test results and clinical narratives). 
They also include manual and/or automated data capture and 
visualization facilities 
Results management 
Facilities for the notification and transfer to the point of care of 
computerized laboratory test results, radiology procedure results reports, 
etc 
Order entry and management 
Support for electronically streamline workflow processes related to 
administrative aspects of healthcare services provision, but also to 
automatically prevent medical errors as for instance in the case of drug-
drug interaction monitoring support in e-prescribing 
Decision support management 
Computer-assisted diagnosis and other computerized decision support 
systems, as for instance processing and editing capabilities for 
standardized and ad-hoc care pathways, and disease treatment and 
management 
Electronic communication and 
connectivity 
Electronic facilities to support the relational needs among care partners 
involved in multidisciplinary and multisetting teams of care, and 
between professionals and patients 
Patient support Electronic facilities for patients education and distance monitoring 
Administrative processes 
Computerized support for administrative processes, including electronic 
scheduling systems for hospital admissions, inpatient and outpatient 
procedures and visits 
Reporting and population health 
management 
Computerized facilities related to hierarchical reporting requirements at 
the national and local levels for reimbursing, patient safety and quality, 
as well as for public health 
Table 1: Core capabilities of an EHR-S elaborated from (Tang, 2003) 
These categories will be discussed further in the following section in which specific implication of 
Disease Management strategies enactment in respect of Healthcare Information Systems capabilities 
will be pointed out.  
5 ENACTMENT IMPLICATION OF THE DISEASE MANAGEMENT 
APPROACH 
The adoption of Healthcare Information Systems, and EHR-S in particular, generally offers a number 
of benefits, including higher quality of care, better patient safety, more efficient information 
processing, and lower administrative costs (Poissant et al., 2005). Nevertheless in these systems, quite 
often, the information management tends to be more oriented to individual patients care supports, and 
several are the reasons.  
Formerly EHR-S are comprehensive information systems fostering the ability to manage, across the  
entire continuum of care, all patients and not just those who are chronically ill. They provide facility 
for enter and access to real-time clinical data and complete documentation of all patient encounters, 
enabling also electronic communication among all players and streamlining the healthcare service 
provision workflow throughout multiple settings. Also, modern interoperable EHR-S, interconnecting 
multiple point of care, interoperate and are historically derived by Electronic Medical Record (EMR), 
local to isolated care delivery organizations. Looking at the clinical and administrative information 
managed by these systems, whereas the latter have been traditionally processed as structured dataset, 
being related to natively structured information (demographics, agendas and working plan scheduling, 
billing, etc), the former were originally captured only as electronic copy of scanned version of paper 
based documents. According to this original purpose of archiving and tracing legal records of what 
happened to patients during their encounter, the lack of computer interpretable representation of 
information limited the possible exploitation of narrative reports to human consultation, relying on few 
documents’ description metadata, entered for the sole purpose to support the indexing and retrieval 
features of some electronic document management systems. For these reason aggregate evaluation of 
homogeneous categories of patients often resulted difficult, with a low granularity and scarcely 
significant. 
Besides, DM is a systemic approach in which not only clinical acts are relevant, but also 
organizational rules and procedures for patient profiling, preventive initiatives, and more in general 
standardization processes focused to ensure that evidence-based and population-based appropriate 
interventions are timely delivered in the adequate settings. Although with a patient-centric view in 
term of healthcare system delivery, in the DM approach the focus is on disease or condition rather than 
on individual patients. The standardization of services and delivery processes, peculiar of care 
management approaches, calls for specific information processing and management, both in the 
operational environment as well as in respect with quality management, outcomes measurements and 
reporting, and public health disease surveillance. 
As a peculiar instance of multidisciplinary and multisettings healthcare services, DM approaches in 
action implies partly overlapping and partly additional functional requirements for Healthcare 
Information Systems. Actually, the core capabilities of a Disease Management Systems (DM-S) would 
be somehow different from those of an EHR-S. In respect with the 8 categories introduced in the 
section above some of the differences result as follow: 
• In respect with health information and data DM-S manage more structured data. This is due to the 
fact that, in DM, not only health information related to individual patient is relevant, but also complete 
and effective view related to single disease affecting a certain population. Actually important features 
for DM-S are patients profiling capabilities using key demographics and clinical data, i.e. a chronicle 
disease diagnostic code, with algorithms to automatically identify all patients who have the same 
medical condition and stratification tools for risks and severity; 
• For result management and order entry and management no specific needs can be highlighted for 
DM-S even if, of course, the presence of these capabilities could have positive impacts on the 
coordination among several different players; 
• For what concern decision support management in the operational environment, built-in care 
pathways templates support for patient management play a central role, being relevant not only for the  
clinical acts but also in order to (semi-)automate the schedule of interventions. Referring to clinical 
aspects, ad hoc features (i.e. charting) for promptly monitoring the progress of the disease on 
individual patients are important. Also capturing the proactive approach of DM, DM-S should include 
reminders and alerts support, at the point of care, related to upcoming and overdue visits and services 
for the assisted population. Besides editing features for ad hoc specifications goals and activities for 
individual patient care appear as being not so relevant for the specific purposes of DM-S; 
• In respect with electronic communication and connectivity, the requirements appear as being not 
so tight. Actually as pointed out in section 3, the standard rules and routines embedded in the care 
pathways results as being an effective basic coordination strategy among healthcare professionals until 
patients conditions remain stable and consistent with the a priori adopted stages of diseases 
classification; 
• In term of patient support, whereas distance monitoring capabilities may greatly vary from disease 
to disease, a peculiar aspect of DM approach is related to patients’ empowerment and couching for 
behavioral changes. In this respect DM-S should include facilities to easily manage and communicate 
patient-education materials as well as specific patient-clinicians relationship support;  
• According to the DM approach, administrative processes refers not only to the traditional 
organization of the point of care, but also to population-based healthcare service delivery, rather 
typical of public health programs. More specifically, DM-S should include outreach tools, such as 
call-back lists and reminder letters, as well as facilities to generate mailing labels and letters to remind 
patients of upcoming and overdue visits, so that providers may print batches of letters at specified 
intervals, and lists of patients who need follow-up; 
• Lastly, referring to reporting and population health management support, the aspects of DM 
related to a continuous quality improvement approach with a population managing scope, implies, as 
additional capabilities for the DM-S, robust and easy to use standard and ad hoc reporting functions, 
both patient-specific (patient summary sheet) and population-focused, as well as sophisticated ready to 
use tools for tracking chronicle disease outcomes. Intuitively these features heavy rely on the 
capabilities to properly define and manage adequate patients dataset, emphasizing the relevance of 
collecting, storing and processing structured, and not narrative, clinical information. 
6 FURTHER CONSIDERATION AND CONCLUSION 
In term of DM programs’ outcomes, there is evidence on substantial quality improvement, but cost 
savings have still to be proven (e.g. (Velasco-Garrido et al., 2003)); it could be justified by the fact 
that it is still in its early stage. Apart from this, one important consideration is that, although there is no 
single model of DM to be applied everywhere, the DM approach has been playing an important role in 
the redesign of healthcare services toward the integration of primary and secondary care, as for 
instance in the Italian IGEA project (http://www.epicentro.iss.it/igea/diabete.asp).  
The IGEA project was launched in 2006 within the Italian NHS, with the aim to define, coordinate and 
harmonize a shared nationwide DM strategy for diabetes. As a former step in the project enactment, 
the upcoming alliance between primary and secondary care implies the establishment of networked 
collaborative working environments. This revealed particularly important in the Italian NHS, where 
the efforts of coordination and harmonization had to be oriented towards two different direction: on 
one side to redesign the healthcare system delivery for the specific disease, i.e. identifying and 
explicitly assigning specific responsibility respectively to community care workers and secondary care 
physicians; on the other to harmonize the regional initiative autonomously conducted in a 
institutionalized healthcare system that, although federated, assumes the equal access to services for 
all the citizens as a fundamental constituent principle. 
Considered the number of stakeholders involved in the process, these tasks revealed particularly 
complex and it is mostly for this reason that the project it is still in its early stage. In particular the 
definition of a complete and well defined shared care pathway for the diabetes, as well as effective 
performance indicators for auditing and continuous process improvement purposes was particularly 
challenging. 
From this, an important lesson learned observing the project evolution is that, although the key 
capabilities of Healthcare Information Systems enabled to support Disease Management strategies 
may be clearly stated a priori, the actual design, development and adoption of a DM-S is heavily 
influenced by the specific peculiarities and objectives related to the particular disease targeted and to 
the environment in which it is enacted. Actually we tried to highlight in the previous section the key 
role played in the DM-S by structured data processing capabilities. Nevertheless a part from technical 
details related to computer-interpretable and interoperable representation of data, the identification of 
appropriate data elements and dataset rather concerns the healthcare processes that are intended to be 
supported and the performance measurements to perform. For this reason future contributions in this 
domain will be oriented to investigate appropriate methodologies and best practices directed to the 
identification and definition of the key data elements, in terms of captured aspects and granularity, 
suitable to support both primary and secondary use of clinical information on routine healthcare. 
7 REFERENCES 
BCG  - The Boston Consulting Group (1995). The Promise of Disease Management. Boston, Mass: 
The Boston Consulting Group Inc.  
Bodenheimer T., Wagner E.H., Grumbach K. (2002). Improving primary Care for Patients with 
Chronic Illness. JAMA, 288:1775-1779. 
Campbell H., Hotchkiss R., Bradshaw N., et al. (1998). Integrated care pathways. BMJ 316:133-137 
CEC – Commission of the European Communities (2004). e-Health - making healthcare better for 
European citizens: An action plan for a European e-Health Area, COM (2004) 356 final. 
Cicchetti A. (2004). La progettazione organizzativa. Principi, strumenti e applicazioni nelle 
organizzazioni sanitarie. Milano, Franco Angeli. 
Contenti M., Albano V., Barbini F.M. (2007). Il Desease Management e la progettazione di 
programmi assistenziali integrati nel Sistema Sanitario Italiano. In proceeding of the VIII 
Workshop dei Docenti e Ricercatori di Organizzazione Aziendale, Reggio-Emilia, Italy. 
Coughlin, J. F., Pope, J. E., et al. (2006). Old Age, New Technology, and Future Innovations in 
Disease Management and Home Health Care.  Home Health Care Management & Practice ,18(3): 
196-207. 
Donabedian, A. (1982). Explorations in quality assessment and monitoring. Michigan, Ann Arbor, 
Health Administration Press. 
Epstein R.S. and Sherwood L.M. (1996). From Outcomes Research to Disease Management: A Guide 
for the Perplexed.  Ann Intern Med, 124(9):832-837.  
Eysenbach, G. (2001). What is e-health?  J Med Internet Res, 3(2):e20. 
Haggerty J.L., Reid R.J., Freeman G.K., et al. (2003). Continuity of care: a multidisciplinary review. 
BMJ, 327:1219-1221. 
Halsted H. (2004). Chronic Disease—The Need for a New Clinical Education. JAMA 292:1057-1059. 
Harris J.M. (1996). Disease Management: New Wine in New Bottles? Ann Intern Med, 124(9):838-
842. 
Hunter D. and Fairfield G. (1997). Managed care: Disease Management. BMJ 315(7099):50-53.  
Iakovidis, I. (1998). Towards personal health record: current situation, obstacles and trends in 
implementation of electronic healthcare record in Europe. International Journal of Medical 
Informatics, 52(1-3):105-115. 
IOM - Institute of Medicine (2001). Crossing the Quality Chasm: A New Health System for the 21st 
Century. Washington D.C.: National Academies Press. 
Jandos L.D. and Holmes M.L. (2006). IT Tools for Chronicle Disease Management: How Do They 
Measure Up. California HealthCare Foundation 
Jones, R., Rogers, R., et al. (2005). What Is eHealth (5): A Research Agenda for eHealth Through 
Stakeholder Consultation and Policy Context Review.  J Med Internet Res, 7(5):e54. 
Laprie J. C. (Ed.) (1992). Dependability: Basic Concepts and Terminology. Springer-Verlag. 
NPfIT - National Programme for Information Technology (2005) Care Pathways v 1.0, NHS Reports. 
Oh, H., Rizo, C., et al. (2005). What Is eHealth (3): A Systematic Review of Published Definitions.  J 
Med Internet Res, 7(1):e1. 
Pagliari, C., Sloan, D., et al. (2005). What Is eHealth (4): A Scoping Exercise to Map the Field.  J Med 
Internet Res, 7(1):e9. 
Poissant L., Pereira J., Tamblyn R., and Kawasumi Y. (2005). The Impact of Electronic Health 
Records on Time Efficiency of Physicians and Nurses: A Systematic Review. JAMIA, 2005 
(12):505-516. 
Rosemberg W. and Donald A. (1995). Evidence based medicine: an approach to clinical problem-
solving.  BMJ, 310(6987):1122-1126. 
Tang P. (2003). Key Capabilities of an Electronic Health Record System. Letter Report. Institute of 
Medicine Committee on Data Standards for Patient Safety. Board on Health Care Services. 
Washington D.C.: National Academies Press. 
Thomson, J. D. (1967). Organizations in Action. New York: McGraw & Hill. 
Velasco-Garrido M., Busse R., et al. (2003). Are disease management programmes (DMPs) effective 
in improving quality of care for people with chronic conditions? WHO Regional Office for 
Europe's Health Evidence Network (HEN), Copenhagen. 
Wagner E.H. (2000). The role of patient care teams in chronic disease management. BMJ, 320:569-
572 
WHO - World Health Organization (2005). Preventing Chronic Disease: a vital investment. WHO 
Press, Geneva. 
Woolf S.H. (1990). Practice guidelines: a new reality in medicine. I. Recent developments. Arch 
Intern Med ,150(9):1811-1818. 
Yach D., Hawkes C., Gould C.L., et al. (2004). The global burden of chronic diseases - Overcoming 
impediments to prevention and control. JAMA, 291 (21):2616-2622. 
